Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Incretin Therapies Do Not Expand β-Cell Mass or Alter Pancreatic Histology in Young Male Mice
Authors
Keywords
-
Journal
ENDOCRINOLOGY
Volume 158, Issue 6, Pages 1701-1714
Publisher
The Endocrine Society
Online
2017-04-19
DOI
10.1210/en.2017-00027
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extreme obesity induces massive beta cell expansion in mice through self-renewal and does not alter the beta cell lineage
- (2016) Aaron R. Cox et al. DIABETOLOGIA
- Glucagon-Like Peptide 1 Analogs and their Effects on Pancreatic Islets
- (2016) Eva Tudurí et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Incretin-based drugs and risk of acute pancreatitis: A nested-case control study within a healthcare database
- (2015) Davide Soranna et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Angiopoietin-like protein 8 (ANGPTL8)/betatrophin overexpression does not increase beta cell proliferation in mice
- (2015) Aaron R. Cox et al. DIABETOLOGIA
- Reanalysis of study of pancreatic effects of incretin therapy: methodological deficiencies
- (2014) S. Bonner-Weir et al. DIABETES OBESITY & METABOLISM
- Hope and fear for new classes of type 2 diabetes drugs: is there preclinical evidence that incretin-based therapies alter pancreatic morphology?
- (2014) Benjamin J Lamont et al. JOURNAL OF ENDOCRINOLOGY
- High fat diet and GLP-1 drugs induce pancreatic injury in mice
- (2014) Rodney Rouse et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- One year of sitagliptin treatment protects against islet amyloid-associated β-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice
- (2013) Kathryn Aston-Mourney et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
- (2013) Jonathan E. Campbell et al. Cell Metabolism
- GLP-1 agonists in type 1 diabetes
- (2013) Jeremy Pettus et al. CLINICAL IMMUNOLOGY
- Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
- (2013) A. E. Butler et al. DIABETES
- Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604
- (2013) S. S. Engel et al. DIABETES
- Comment on: Butler et al. Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors. Diabetes 2013;62:2595-2604
- (2013) R. J. Heine et al. DIABETES
- Occurrence of Spontaneous Pancreatic Lesions in Normal and Diabetic Rats: A Potential Confounding Factor in the Nonclinical Assessment of GLP-1-Based Therapies
- (2013) K. D. Chadwick et al. DIABETES
- -Cells Are Not Generated in Pancreatic Duct Ligation-Induced Injury in Adult Mice
- (2013) M. M. Rankin et al. DIABETES
- An Analysis of Characteristics of Subjects Examined for Incretin Effects on Pancreatic Pathology
- (2013) Evis Harja et al. Diabetes Technology & Therapeutics
- Glucagon-like peptide-1 receptor agonist treatment reduces beta cell mass in normoglycaemic mice
- (2013) J. H. Ellenbroek et al. DIABETOLOGIA
- Stimulating β-Cell Regeneration by Combining a GPR119 Agonist with a DPP-IV Inhibitor
- (2013) Ansarullah et al. PLoS One
- Chronic GLP-1 Receptor Activation by Exendin-4 Induces Expansion of Pancreatic Duct Glands in Rats and Accelerates Formation of Dysplastic Lesions and Chronic Pancreatitis in the KrasG12DMouse Model
- (2012) Belinda Gier et al. DIABETES
- Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes
- (2012) S. M. Poucher et al. DIABETES OBESITY & METABOLISM
- Effect of sitagliptin plus metformin on β-cell function, islet integrity and islet gene expression in Zucker diabetic fatty rats
- (2011) Seung Jin Han et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1–Based Therapies
- (2011) Michael Elashoff et al. GASTROENTEROLOGY
- Aging induces a distinct gene expression program in mouse islets
- (2011) Matthew M. Rankin et al. Islets
- The DPP-4 inhibitor vildagliptin increases pancreatic beta cell mass in neonatal rats
- (2010) Alokesh Duttaroy et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effects of exendin-4 on glucose tolerance, insulin secretion, and beta-cell proliferation depend on treatment dose, treatment duration and meal contents
- (2009) Masayuki Arakawa et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Glucagon-Like Peptide-1 Receptor Activation Modulates Pancreatitis-Associated Gene Expression But Does Not Modify the Susceptibility to Experimental Pancreatitis in Mice
- (2009) J. A. Koehler et al. DIABETES
- Adaptive -Cell Proliferation Is Severely Restricted With Advanced Age
- (2009) M. M. Rankin et al. DIABETES
- Cyclin D2 Protein Stability Is Regulated in Pancreatic β-Cells
- (2009) Lu Mei He et al. MOLECULAR ENDOCRINOLOGY
- -Cell Replication Is the Primary Mechanism Subserving the Postnatal Expansion of -Cell Mass in Humans
- (2008) J. J. Meier et al. DIABETES
- Chronic Antidiabetic Sulfonylureas In Vivo: Reversible Effects on Mouse Pancreatic β-Cells
- (2008) Maria Sara Remedi et al. PLOS MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started